Literature DB >> 25797492

Neuro-anatomic mapping of dopamine D1 receptor involvement in nicotine self-administration in rats.

Brandon J Hall1, Susan Slade1, Cheyenne Allenby1, Munir G Kutlu2, Edward D Levin3.   

Abstract

Dopaminergic signaling has long been known to be a critical factor in nicotine addiction, as well as other drugs of abuse. Dopaminergic projections from the VTA to the nucleus accumbens and prefrontal cortex have been well established to be critical to the reinforcing effects of these drugs. However, other projections of dopamine neurons are likely to have significant roles in this process. Also, the relative contributions of D1 and D2 dopamine receptors in drug addiction and its treatment remain to be fully understood. In this study, we examined the effects of blocking D1 and D2 receptors in the nucleus accumbens shell (AcS), anterior cingulate cortex (ACC), and parietal association cortex (PtA) on nicotine self-administration in rats. Female Sprague-Dawley rats were fitted with jugular catheters and allowed to self-administer nicotine (0.03 mg/kg/infusion) on an FR1 schedule. Rats were fitted with bilateral infusion cannulae to allow infusion of D1 or D2 antagonists (SCH-23390 or haloperidol) into each targeted brain area. Acute local infusions of SCH-23390 (1-4 μg/side) into the AcS and PtA significantly reduced nicotine self-administration by up to 75%. SCH-23390 infusion into the ACC was less effective with only suggestive non-significant reductions of nicotine self-administration. Acute, local infusions of haloperidol (0.5-2 μg/side) in any of the brain regions targeted did not have significant effects on nicotine self-administration. These results demonstrate a more significant role for D1 receptor mechanisms in the process of nicotine reinforcement and help provide a more detailed neuroanatomic map of nicotine dependence in the brain.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Anterior cingulate cortex; Dopamine; Nicotine; Nucleus accumbens; Parietal cortex; Self-administration

Mesh:

Substances:

Year:  2015        PMID: 25797492      PMCID: PMC4575603          DOI: 10.1016/j.neuropharm.2015.03.005

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  45 in total

1.  Neuronal activity in monkey ventral striatum related to the expectation of reward.

Authors:  W Schultz; P Apicella; E Scarnati; T Ljungberg
Journal:  J Neurosci       Date:  1992-12       Impact factor: 6.167

2.  Regional cerebral blood flow responses to smoking in tobacco smokers after overnight abstinence.

Authors:  Jon-Kar Zubieta; Mary M Heitzeg; Yanjun Xu; Robert A Koeppe; Lisong Ni; Sally Guthrie; Edward F Domino
Journal:  Am J Psychiatry       Date:  2005-03       Impact factor: 18.112

Review 3.  Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates.

Authors:  Jeffrey W Dalley; Rudolf N Cardinal; Trevor W Robbins
Journal:  Neurosci Biobehav Rev       Date:  2004-11       Impact factor: 8.989

4.  Abstinence-induced changes in self-report craving correlate with event-related FMRI responses to smoking cues.

Authors:  F Joseph McClernon; F Berry Hiott; Scott A Huettel; Jed E Rose
Journal:  Neuropsychopharmacology       Date:  2005-10       Impact factor: 7.853

5.  Role for cingulate motor area cells in voluntary movement selection based on reward.

Authors:  K Shima; J Tanji
Journal:  Science       Date:  1998-11-13       Impact factor: 47.728

Review 6.  Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.

Authors:  P Seeman; T Tallerico
Journal:  Mol Psychiatry       Date:  1998-03       Impact factor: 15.992

7.  Nicotine-induced decreases in VTA electrical self-stimulation thresholds: blockade by haloperidol and mecamylamine but not scopolamine or ondansetron.

Authors:  S Ivanová; A J Greenshaw
Journal:  Psychopharmacology (Berl)       Date:  1997-11       Impact factor: 4.530

8.  Human anterior cingulate neurons and the integration of monetary reward with motor responses.

Authors:  Ziv M Williams; George Bush; Scott L Rauch; G Rees Cosgrove; Emad N Eskandar
Journal:  Nat Neurosci       Date:  2004-11-21       Impact factor: 24.884

Review 9.  Predictive reward signal of dopamine neurons.

Authors:  W Schultz
Journal:  J Neurophysiol       Date:  1998-07       Impact factor: 2.714

10.  Evidence for an involvement of D1 and D2 dopamine receptors in mediating nicotine-induced hyperactivity in rats.

Authors:  M F O'Neill; C T Dourish; S D Iversen
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

View more
  10 in total

1.  An analysis of the rewarding and aversive associative properties of nicotine in the neonatal quinpirole model: Effects on glial cell line-derived neurotrophic factor (GDNF).

Authors:  Russell W Brown; Seth L Kirby; Adam R Denton; John M Dose; Elizabeth D Cummins; Wesley Drew Gill; Katherine C Burgess
Journal:  Schizophr Res       Date:  2017-03-14       Impact factor: 4.939

2.  Impaired Acquisition of Nicotine-Induced Conditioned Place Preference in Fatty Acid-Binding Protein 3 Null Mice.

Authors:  Wenbin Jia; Gofarana Wilar; Ichiro Kawahata; An Cheng; Kohji Fukunaga
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

3.  Crucial Role of Dopamine D2 Receptor Signaling in Nicotine-Induced Conditioned Place Preference.

Authors:  Gofarana Wilar; Yasuharu Shinoda; Toshikuni Sasaoka; Kohji Fukunaga
Journal:  Mol Neurobiol       Date:  2019-05-25       Impact factor: 5.590

4.  Prolonging the Reduction of Nicotine Self-Administration in Rats by Coadministering Chronic Nicotine With Amitifadine, a Triple Monoamine Reuptake Inhibitor With CYP2B6 Inhibitory Actions.

Authors:  Edward D Levin; Corinne Wells; Susan Slade; Michelle Lee; Anthony A McKinney; Jed E Rose; Amir H Rezvani
Journal:  Nicotine Tob Res       Date:  2020-02-06       Impact factor: 4.244

5.  The ventral hippocampal muscarinic cholinergic system plays a key role in sexual dimorphisms of spatial working memory in rats.

Authors:  Brandon J Hall; Yael Abreu-Villaça; Marty Cauley; Shaqif Junaid; Hannah White; Abtin Kiany; Edward D Levin
Journal:  Neuropharmacology       Date:  2017-01-26       Impact factor: 5.250

6.  Acute and chronic interactive treatments of serotonin 5HT2C and dopamine D1 receptor systems for decreasing nicotine self-administration in female rats.

Authors:  Blair K A Willette; Anica Nangia; Sarah Howard; Devon DiPalma; Collin McMillan; Sonum Tharwani; Janequia Evans; Corinne Wells; Susan Slade; Brandon J Hall; Amir H Rezvani; Edward D Levin
Journal:  Pharmacol Biochem Behav       Date:  2019-08-27       Impact factor: 3.697

7.  Persistent attenuation of nicotine self-administration in rats by co-administration of chronic nicotine infusion with the dopamine D1 receptor antagonist SCH-23390 or the serotonin 5-HT2C agonist lorcaserin.

Authors:  Devon DiPalma; Amir H Rezvani; Blair Willette; Corinne Wells; Susan Slade; Brandon J Hall; Edward D Levin
Journal:  Pharmacol Biochem Behav       Date:  2018-11-09       Impact factor: 3.697

Review 8.  Presynaptic G Protein-Coupled Receptors: Gatekeepers of Addiction?

Authors:  Kari A Johnson; David M Lovinger
Journal:  Front Cell Neurosci       Date:  2016-11-11       Impact factor: 5.505

9.  Dopamine D1-like receptor blockade and stimulation decreases operant responding for nicotine and food in male and female rats.

Authors:  Ranjithkumar Chellian; Azin Behnood-Rod; Ryann Wilson; Karen Lin; Grace Wing-Yan King; Marcella Ruppert-Gomez; Alexandria Nicole Teter; Marcelo Febo; Adriaan W Bruijnzeel
Journal:  Sci Rep       Date:  2022-08-19       Impact factor: 4.996

10.  Opioid Self-Administration is Attenuated by Early-Life Experience and Gene Therapy for Anti-Inflammatory IL-10 in the Nucleus Accumbens of Male Rats.

Authors:  Michael J Lacagnina; Ashley M Kopec; Stewart S Cox; Richa Hanamsagar; Corinne Wells; Susan Slade; Peter M Grace; Linda R Watkins; Edward D Levin; Staci D Bilbo
Journal:  Neuropsychopharmacology       Date:  2017-04-24       Impact factor: 7.853

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.